ArticleInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2024

Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study.

Premal H Thaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.